2006 - Fellow of the American Association for the Advancement of Science (AAAS)
The scientist’s investigation covers issues in Immunology, Acquired immunodeficiency syndrome, Viral disease, Internal medicine and Virology. His Immunology study incorporates themes from Incidence, Cohort and Risk factor. His Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Psychiatry and Epidemiology.
Kenrad E. Nelson has included themes like Hepatitis A, Hepatitis, Immunopathology, Vaccination and Drug injection in his Viral disease study. His study on Odds ratio and Survival analysis is often connected to Incubation period as part of broader study in Internal medicine. The concepts of his Virology study are interwoven with issues in Hepatitis E, Antibody and Hepatitis E virus.
His primary areas of study are Immunology, Virology, Acquired immunodeficiency syndrome, Internal medicine and Epidemiology. His Immunology study combines topics in areas such as Incidence, Cohort and Risk factor. His Virology research is multidisciplinary, incorporating perspectives in Antibody and Genotype, Hepatitis E virus.
His research integrates issues of Seroconversion and Cohort study in his study of Acquired immunodeficiency syndrome. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Surgery. His Epidemiology research incorporates themes from Developing country, Public health and Intensive care medicine.
Kenrad E. Nelson spends much of his time researching Virology, Hepatitis E virus, Immunology, Hepatitis E and Seroprevalence. His studies in Virology integrate themes in fields like Odds ratio, Antibody, Epidemiology and Genotype. His Immunology study typically links adjacent topics like Jaundice.
His biological study spans a wide range of topics, including Viral hepatitis, Immunoglobulin M, Seroconversion and Hepatitis. His study explores the link between Viral load and topics such as Viremia that cross with problems in Internal medicine. His studies deal with areas such as Acquired immunodeficiency syndrome, Cohort study and Drug as well as Incidence.
Kenrad E. Nelson mostly deals with Virology, Hepatitis E virus, Hepatitis E, Transmission and Environmental health. The Virology study combines topics in areas such as Infectious Disease Epidemiology and Disease burden. His Hepatitis E virus study integrates concerns from other disciplines, such as Seroprevalence and Immunology.
His Immunology study often links to related topics such as Internal medicine. He has researched Transmission in several fields, including Hepatitis B, Pregnancy, Hepatitis C, Breastfeeding and Hepatitis B virus. His Environmental health study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
David L. Thomas;Jacquie Astemborski;Rudra M. Rai;Frank A. Anania.
The Declining Risk of Post-Transfusion Hepatitis C Virus Infection
James G. Donahue;Alvaro Muñoz;Paul M. Ness;Donald E. Brown.
The New England Journal of Medicine (1992)
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses
Richard S. Garfein;David Vlahov;Noya Galai;Meg C. Doherty.
American Journal of Public Health (1996)
Incubation periods of acute respiratory viral infections: a systematic review
Justin Lessler;Nicholas G Reich;Ron Brookmeyer;Trish M Perl;Trish M Perl.
Lancet Infectious Diseases (2009)
Disseminated Penicillium marneffei infection in southeast Asia
K Supparatpinyo;C Khamwan;V Baosoung;T Sirisanthana.
The Lancet (1994)
Persistence of Viremia and the Importance of Long Term Follow-up after Acute Hepatitis C Infection
Stephen A. Villano;David Vlahov;Kenrad E. Nelson;Sylvia Cohn.
CORRELATES OF HEPATITIS C VIRUS INFECTIONS AMONG INJECTION DRUG USERS
David L. Thomas;David Vlahov;Liza Solomon;Sylvia Cohn.
Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors
M.P. Busch;L.L.L. Lee;G.A. Satten;D.R. Henrard.
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.
Richard S. Garfein;Meg C. Doherty;Edgar R. Monterroso;David L. Thomas.
Journal of Acquired Immune Deficiency Syndromes (1998)
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.
Steffanie A. Strathdee;Noya Galai;Mahboobeh Safaiean;David D. Celentano.
JAMA Internal Medicine (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: